Healthcare & Life Sciences
UroGen Pharma
Israelwww.urogen.com
UroGen Pharma is a Healthcare & Life Sciences startup based in Israel, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About UroGen Pharma
UroGen Pharma is a company headquartered in Israel. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
UroGen Pharma is a biopharmaceutical company that develops innovative treatments for uro-oncology and other urological diseases, leveraging its proprietary RTGel drug delivery technology.
Explore UroGen Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.